GPCR; Orphan GPCR; GPR27; Arrestin; Insulin; Screening; Surrogate agonist; small molecules; G Protein; Orphan; Luciferase
Abstract :
[en] G protein-coupled receptors are the most important drug targets for human diseases. An important number of them remain devoid of confirmed ligands. GPR27 is one of these orphan receptors, characterized by a high level of conservation among vertebrates and a predominant expression in the central nervous system. In addition, it has recently been linked to insulin secretion. However, the absence of endogenous or surrogate ligands for GPR27 complicates the examination of its biological function. Our aim was to validate GPR27 signaling pathways and therefore we sought to screen a diversity oriented synthesis library to identify GPR27-specific surrogate agonists. In order to select an optimal screening assay, we investigated GPR27 ligand-independent activity. Both in G protein-mediated pathways and in β-arrestin 2 recruitment, no ligand-independent activity could be measured. However, we observed a recruitment of β-arrestin 2 to a GPR27V2 chimera in the presence of membrane-anchored β-adrenergic receptor kinase 1 (GRK2). Therefore, we optimized a firefly luciferase complementation assay to screen against this chimeric receptor. We identified two compounds (N-[4-(anilinocarbonyl)phenyl]-2,4-dichlorobenzamide (ChemBridge ID5128535) and 2,4-dichloro-N-{4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}benzamide (ChemBridge ID5217941)) sharing a N-phenyl-2,4-dichlorobenzamide scaffold, which were selective for GPR27 over its closely related family members GPR85 and GPR173. The specificity of the activity was confirmed with a NanoBiT® β-arrestin 2 assay, imaging of GFP-tagged β-arrestin 2 and PathHunter® β-arrestin 2 Assay. Interestingly, no G protein activation was detected upon activation of GPR27 by these compounds. Our study provides the first selective surrogate agonists for the orphan GPR27.
Ahmad R, Wojciech S, and Jockers R (2015) Hunting for the function of orphan GPCRs-beyond the search for the endogenous ligand. Br J Pharmacol 172: 3212-3228.
Al-Sabah S, Al-Fulaij M, Shaaban G, Ahmed HA, Mann RJ, Donnelly D, Bünemann M, and Krasel C (2014) The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively. PLoS One 9: e106890.
Barak LS, Ferguson SS, Zhang J, and Caron MG (1997) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272:27497-27500.
Barak LS, Oakley RH, Laporte SA, and Caron MG (2001) Constitutive arrestinmediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 98:93-98.
Baubet V, Le Mouellic H, Campbell AK, Lucas-Meunier E, Fossier P, and Brúlet P (2000) Chimeric green fluorescent protein-aequorin as bioluminescent Ca21 reporters at the single-cell level. Proc Natl Acad Sci USA 97:7260-7265.
Bond RA and Ijzerman AP (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92-96.
Cannaert A, Storme J, Franz F, Auwärter V, and Stove CP (2016) Detection and activity profiling of synthetic cannabinoids and metabolites with a newly developed bio-assay. Anal Chem 88:11476-11485.
Cao W, Luttrell LM, Medvedev AV, Pierce KL, Daniel KW, Dixon TM, Lefkowitz RJ, and Collins S (2000) Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 275:38131-38134.
Chevigné A, Fievez V, Szpakowska M, Fischer A, Counson M, Plesséria JM, Schmit JC, and Deroo S (2014) Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection. Biochim Biophys Acta 1843:1031-1041.
Civelli O, Reinscheid RK, Zhang Y, Wang Z, Fredriksson R, and Schiöth HB (2013) G protein-coupled receptor deorphanizations. Annu Rev Pharmacol Toxicol 53: 127-146.
Costa T and Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325.
Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, Liew WC, Mpamhanga CP, Bonner TI, Neubig RR, et al. (2013) International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev 65: 967-986.
Defea K (2008) Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br J Pharmacol 153 (Suppl 1):S298-S309.
DeGraff JL, Gagnon AW, Benovic JL, and Orsini MJ (1999) Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes. J Biol Chem 274:11253-11259.
DeGraff JL, Gurevich VV, and Benovic JL (2002) The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction. J Biol Chem 277:43247-43252.
Dixon AS, Schwinn MK, Hall MP, Zimmerman K, Otto P, Lubben TH, Butler BL, Binkowski BF, Machleidt T, Kirkland TA, et al. (2016) NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem Biol 11:400-408.
Fredriksson R, Lagerström MC, Lundin LG, and Schiöth HB (2003) The G-proteincoupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256-1272.
Gilissen J, Geubelle P, Dupuis N, Laschet C, Pirotte B, and Hanson J (2015) Forskolin-free cAMP assay for Gi-coupled receptors. Biochem Pharmacol 98: 381-391.
Guan XM, Kobilka TS, and Kobilka BK (1992) Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem 267:21995-21998.
Hanson J and Chevigné A (2016) GPCRs in immunity: atypical receptors and novel concepts. Biochem Pharmacol 114:1-2.
Hanson J, Ferreirós N, Pirotte B, Geisslinger G, and Offermanns S (2013) Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4. Biochem Pharmacol 85:1795-1802.
Hennen S, Wang H, Peters L, Merten N, Simon K, Spinrath A, Blättermann S, Akkari R, Schrage R, Schröder R, et al. (2013) Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist. Sci Signal 6:ra93.
Hislop JN, Caunt CJ, Sedgley KR, Kelly E, Mundell S, Green LD, and McArdle CA (2005) Internalization of gonadotropin-releasing hormone receptors (GnRHRs): does arrestin binding to the C-terminal tail target GnRHRs for dynamindependent internalization? J Mol Endocrinol 35:177-189.
Huang XP, Karpiak J, Kroeze WK, Zhu H, Chen X, Moy SS, Saddoris KA, Nikolova VD, Farrell MS, Wang S, et al. (2015) Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature 527:477-483.
Inglese J, Koch WJ, Caron MG, and Lefkowitz RJ (1992) Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 359:147-150.
Inoue A, Ishiguro J, Kitamura H, Arima N, Okutani M, Shuto A, Higashiyama S, Ohwada T, Arai H, Makide K, et al. (2012) TGFa shedding assay: an accurate and versatile method for detecting GPCR activation. Nat Methods 9:1021-1029.
Isberg V, Andersen KB, Bisig C, Dietz GP, Bräuner-Osborne H, and Gloriam DE (2014) Computer-aided discovery of aromatic l-a-amino acids as agonists of the orphan G protein-coupled receptor GPR139. J Chem Inf Model 54:1553-1557.
Kenakin T (2015a) The effective application of biased signaling to new drug discovery. Mol Pharmacol 88:1055-1061.
Kenakin T (2015b) New lives for seven transmembrane receptors as drug targets. Trends Pharmacol Sci 36:705-706.
Kenakin T and Christopoulos A (2013) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12:205-216.
Kenakin TP (2009) Cellular assays as portals to seven-transmembrane receptorbased drug discovery. Nat Rev Drug Discov 8:617-626.
Kostenis E (2001) Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors? Trends Pharmacol Sci 22:560-564.
Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguère PM, Sciaky N, and Roth BL (2015) PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat Struct Mol Biol 22:362-369.
Ku GM, Pappalardo Z, Luo CC, German MS, and McManus MT (2012) An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production. PLoS Genet 8:e1002449.
Lefkowitz RJ and Shenoy SK (2005) Transduction of receptor signals by betaarrestins. Science 308:512-517.
Levoye A and Jockers R (2008) Alternative drug discovery approaches for orphan GPCRs. Drug Discov Today 13:52-58.
Loison S, Cottet M, Orcel H, Adihou H, Rahmeh R, Lamarque L, Trinquet E, Kellenberger E, Hibert M, Durroux T, et al. (2012) Selective fluorescent nonpeptidic antagonists for vasopressin V2 GPCR: application to ligand screening and oligomerization assays. J Med Chem 55:8588-8602.
Luker KE, Steele JM, Mihalko LA, Ray P, and Luker GD (2010) Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29:4599-4610.
Luttrell LM and Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305-330.
Martin AL, Steurer MA, and Aronstam RS (2015) Constitutive activity among orphan class-A G protein coupled receptors. PLoS One 10:e0138463.
Masuho I, Ostrovskaya O, Kramer GM, Jones CD, Xie K, and Martemyanov KA (2015) Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors. Sci Signal 8:ra123.
Matsumoto M, Saito T, Takasaki J, Kamohara M, Sugimoto T, Kobayashi M, Tadokoro M, Matsumoto S, Ohishi T, and Furuichi K (2000) An evolutionarily conserved G-protein coupled receptor family, SREB, expressed in the central nervous system. Biochem Biophys Res Commun 272:576-582.
Munk C, Isberg V, Mordalski S, Harpsøe K, Rataj K, Hauser AS, Kolb P, Bojarski AJ, Vriend G, and Gloriam DE (2016) GPCRdb: the G protein-coupled receptor database-an introduction. Br J Pharmacol 173:2195-2207.
Nantel F, Bonin H, Emorine LJ, Zilberfarb V, Strosberg AD, Bouvier M, and Marullo S (1993) The human beta 3-adrenergic receptor is resistant to short term agonistpromoted desensitization. Mol Pharmacol 43:548-555.
Ngo T, Kufareva I, Coleman JLj, Graham RM, Abagyan R, and Smith NJ (2016) Identifying ligands at orphan GPCRs: current status using structure-based approaches. Br J Pharmacol 173:2934-2951.
Oakley RH, Hudson CC, Cruickshank RD, Meyers DM, Payne, JrRE, Rhem SM, and Loomis CR (2002) The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay Drug Dev Technol 1:21-30.
Oakley RH, Hudson CC, Sjaastad MD, and Loomis CR (2006) The ligandindependent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. Methods Enzymol 414:50-63.
Oakley RH, Laporte SA, Holt JA, Caron MG, and Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210.
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, and Lefkowitz RJ (2010) Beta-arrestin-but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci USA 107:628-632.
Rask-Andersen M, Almén MS, and Schiöth HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10:579-590.
Regard JB, Sato IT, and Coughlin SR (2008) Anatomical profiling of G proteincoupled receptor expression. Cell 135:561-571.
Reitman ML, Dishy V, Moreau A, Denney WS, Liu C, Kraft WK, Mejia AV, Matson MA, Stoch SA, Wagner JA, et al. (2012) Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients. J Clin Pharmacol 52:1306-1316.
Roth BL and Kroeze WK (2015) Integrated approaches for genome-wide interrogation of the druggable non-olfactory G protein-coupled receptor superfamily. J Biol Chem 290:19471-19477.
Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, and Lefkowitz RJ (2006) beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:1261-1273.
Shenoy SK and Lefkowitz RJ (2005) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280:15315-15324.
Snyder JC, Rochelle LK, Barak LS, and Caron MG (2013) The stem cell-expressed receptor Lgr5 possesses canonical and functionally active molecular determinants critical to b-arrestin-2 recruitment. PLoS One 8:e84476.
Szpakowska M, Dupuis N, Baragli A, Counson M, Hanson J, Piette J, and Chevigné A (2016) Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7. Biochem Pharmacol 114:14-21.
Takakura H, Hattori M, Takeuchi M, and Ozawa T (2012) Visualization and quantitative analysis of G protein-coupled receptor-b-arrestin interaction in single cells and specific organs of living mice using split luciferase complementation. ACS Chem Biol 7:901-910.
Verkaar F, van Rosmalen JW, Blomenröhr M, van Koppen CJ, Blankesteijn WM, Smits JF, and Zaman GJ (2008) G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors. Biotechnol Annu Rev 14:253-274.
Wettschureck N and Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159-1204.
Yanai T, Kurosawa A, Nikaido Y, Nakajima N, Saito T, Osada H, Konno A, Hirai H, and Takeda S (2016) Identification and molecular docking studies for novel inverse agonists of SREB, super conserved receptor expressed in brain. Genes Cells 21: 717-727.
Zhang JH, Chung TD, and Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73.
Zhu T, Fang LY, and Xie X (2008) Development of a universal high-throughput calcium assay for G-protein-coupled receptors with promiscuous G-protein Galpha15/ 16. Acta Pharmacol Sin 29:507-516.